Companies Registration Office
Week of 2026-W11
Irish Corporate Affairs Weekly
CRO Company & Business Formations, Financial Filings & Director Networks — Week of 12–16 March 2026
Source: CRO | Period: 2026-03-12 to 2026-03-16
Healthcare Dominates the Filing Week: 2,035 Reports Filed, 193 New Business Names, and a Sandyford Medical Empire Reveals Its Numbers
The week of 12–16 March 2026 was defined not by new company formations — the CRO registered zero new companies in the period — but by a wave of financial disclosures that laid bare the health of Irish enterprise. With 2,035 financial statements received, the filing queue delivered a striking concentration of healthcare sector accounts: from a debt-free Sandyford medical group generating €16.1 million in revenue, to a Dundrum-based healthcare billing platform growing at 18% annually, to a Cork pharmacist running a group that spans dispensaries, a veterinary practice, a pub, and a dairy farm. Meanwhile, 193 new business names were registered across the country, with a Tullamore motor dealer registering five brand names in a single day and Toshiba's UK imaging division quietly establishing an Irish office.
By the Numbers
| Metric | Value | Signal |
|---|---|---|
| Financial reports filed (week) | 2,035 | High volume |
| Consolidated group accounts filed | 9 | Largest groups |
| Business names registered | 193 | Steady |
| New company formations | 0 | None this week |
| Highest revenue filed (Medical Account Services) | €21.4M | +18% YoY |
| Largest property transaction (week) | €29.1M | Top deal |
| Avg property price (week) | €468,601 | Above median |
| Median property price (week) | €352,423 | Market level |
Medical Account Services Limited — a Dundrum-based company providing billing and accounts receivable management for healthcare professionals — grew revenue 18% to €21.4 million in the year to April 2025. The company now operates subsidiaries in the UK (Medserv Limited) and Poland (MAS Polska Sp. z.o.o.), and continues to invest in R&D. This is not a startup story: it is a quietly scaling Irish SaaS business in a sector — healthcare administration — that is structurally growing as the Irish health system expands. The 2026 accounts will test whether that growth rate is sustainable.
Zero new company formations in a five-day window is unusual — the CRO typically processes dozens per week. This likely reflects a data timing gap rather than a structural slowdown, as the 193 business name registrations confirm normal entrepreneurial activity. The business name cohort this week skews heavily toward sole traders and micro-enterprises: food service, construction trades, wellness, and IT consultancy dominate. Notably, five O'Briens Motor Group brand names were registered on the same day in Tullamore — a pattern consistent with a franchise or multi-brand dealer preparing for a new model rollout.
When no new companies are registered in a given week, the CRO's story is told entirely through financial filings — and this week's filings tell a rich one. The 2,035 statements received between 12–16 March 2026 include nine consolidated group accounts (the most complex and revealing filings, covering multi-entity structures) alongside 2,026 standard financial statements. The consolidated accounts alone span healthcare services, pharmacy, pharma-to-mining pivots, and fire protection — a cross-section of Irish enterprise that rewards close reading.
Financial Performance: Top Filings This Week
| Company | Revenue | Profit/(Loss) | Total Assets | Employees | Auditor |
|---|---|---|---|---|---|
| Medical Account Services Ltd View | €21.4M | €115K | €9.98M | N/D | Ormsby & Rhodes |
| Beacon Medical Group Ltd View | €16.1M | €2.31M | €25.5M | 97 | Grant Thornton |
| Classes Lake Pharmacy Ltd View | €12.9M | €113K | €6.58M | 100 | C.M. Calnan & Co. |
| Ovoca Bio PLC View | €0 | (€746K) | €2.65M | 0 | Grant Thornton |
| Radiator Plus Limited View | N/D | (€151K) | €176K | N/D | Unaudited |
| Taaffe Training Limited View | N/D | N/D | £86K | 2 | LT Financial Services |
Medical Account Services Limited grew revenue from €18.1 million to €21.4 million in the year to April 2025 — a 18.1% increase that outpaces most Irish services businesses. The company holds €4.9 million in cash at year-end, carries only €66,667 in bank debt, and has expanded into the UK and Poland. Directors Cormac Loughrey and John Loughrey drew a combined director loan of €181,797 during the year. The operating margin is thin (0.55%) but the cash generation is strong — a business that is investing in growth rather than extracting profit.
Ovoca Bio PLC (CRO: 105274), listed on both Euronext Growth Dublin and London's AIM, filed accounts showing the parent company in a net liability position of €11.6 million at 31 December 2024. The group's auditors, Grant Thornton, flagged a material uncertainty over going concern. The company has abandoned its Orenetide drug programme following failed Phase II trials, sold its Russian subsidiary for a nominal sum, and is now pursuing a conditional acquisition of Moroccan copper and silver exploration licences. Timothy McCutcheon, who joined as CEO in August 2024, holds 19.5 million shares (22% of issued capital). The question for 2025 accounts: has the Morocco deal closed, and does the company have sufficient cash to execute a mining pivot?
Business Name Registrations: Sector Breakdown
The 193 business names registered this week span a wide range of sectors. The dominant themes are food service, construction trades, IT/tech, and personal wellness — consistent with the broader pattern of Irish micro-enterprise formation.
The financial filings of any given week are a snapshot of decisions made 12–18 months earlier — the year-end accounts now arriving at the CRO reflect the trading conditions of 2024 and early 2025. What this week's cohort reveals is a healthcare sector that is quietly consolidating, a public company in existential transition, and a Cork entrepreneur who has built one of Ireland's most unusual diversified groups. The connections between these stories are structural, not coincidental.
Three of the nine consolidated accounts filed this week are healthcare businesses: Beacon Medical Group Limited, Medical Account Services Limited, and Classes Lake Pharmacy Ltd. Together they employ nearly 300 people, generate over €50 million in combined revenue, and are all profitable. The pattern is not coincidental — healthcare is one of the few Irish sectors where demand is structurally guaranteed by demographics and government spending. The CRO data confirms what the HSE budget debates suggest: private healthcare infrastructure in Ireland is growing, not contracting.
Mark Redmond, director of Beacon Medical Group Limited, is also active director of at least six other live Beacon-branded entities at the CRO: Beacon Dialysis Services Limited, Beacon Hospital Car Park Limited, Beacon Medical Holdings Limited, Cerdera Limited (property development), Bagnasco Limited (management services), and U-Scribe Group Limited. The group's accounts disclose related-party transactions with Beacon Nursing Homes Limited (an €830,000 loan outstanding since 2019), Beacon Medical Holdings (a €1.845 million advance during the year), and Beacon Care Fertility Limited (€250,000 in management charges). This is a tightly integrated corporate ecosystem — the filing of one set of accounts illuminates the whole network. Watch for the Beacon Medical Holdings accounts to arrive at the CRO in the coming months.
Classes Lake Pharmacy Ltd, run by director Dan McCarthy from Bandon, Co. Cork, filed consolidated accounts covering a group that includes four pharmacy shops, a veterinary practice, a public house, and a dairy farm — all controlled through a "golden share" structure that gives McCarthy effective control without majority shareholding. Revenue grew from €12.3 million to €12.9 million (4.9%), but profit fell from €193K to €113K as interest costs rose to €336K. The group carries €2.2 million in long-term debt, including €681K in deferred PAYE/PRSI — a legacy of the pandemic-era warehousing scheme. The question for 2026 accounts: can the group reduce its interest burden as rates normalise, and will the dairy farm and pub contribute meaningfully to the bottom line?
The Business Post reported this week that Wtech Fire opened a new €2.5 million headquarters in Mullingar and announced three new acquisitions, bringing its total to 13 companies acquired since being majority-acquired by Dutch PE firm Waterland Ireland. The company now generates €123.4 million in revenue and employs 860 people. What the Business Post article does not report: Wtech Fire's original entity, Writech, was founded in 1985 and remains a separate CRO-registered company. The PE-backed acquisition wave in Irish fire protection — a sector that serves data centres, renewable energy plants, and power substations — is a direct consequence of Ireland's infrastructure buildout. Watch for further consolidation in this sector as data centre construction continues.
Among the 193 business names registered this week, one stands out for its corporate pedigree: Toshiba TEC U.K. Imaging Systems Ireland Office (business num 783444), registered on 16 March 2026 at The Black Church, St. Mary's Place, Dublin D07 P4AX. The registration is under the "manufacture of computers and peripheral equipment" NACE code, but Toshiba TEC's core business is document management and imaging systems. The Black Church address is a well-known Dublin serviced office hub. This is not a manufacturing operation — it is a sales or support office. The so what: Toshiba TEC is establishing a direct Irish presence, likely to serve the growing enterprise market. Watch for a formal company incorporation in the coming months.
The Radar: Three Signals Worth Watching
Medical Account Services Limited now has subsidiaries in the UK (Medserv Limited) and Poland (MAS Polska Sp. z.o.o.), with revenue up 18% to €21.4 million. This is not an isolated case — the structural growth of private healthcare in Ireland and the UK is creating demand for specialist billing and revenue cycle management services. The company's R&D investment suggests product development is ongoing. Watch for: a further revenue acceleration in the 2026 accounts, and potentially a third international market entry.
Five O'Briens Motor Group brand names — O'Briens, O'Briens Motor Group, O'Briens Renault, O'Briens MG, and O'Briens Dacia — were all registered on the same day (16 March 2026) at Church Road, Tullamore, Offaly. This pattern of same-day, same-address multi-brand registrations is consistent with a dealer group preparing for a franchise restructuring or new model launch. The Dacia and MG brands are among the fastest-growing in the Irish new car market. Watch for: a formal company incorporation or franchise agreement announcement in the coming weeks.
Chemist Warehouse Nenagh (business num 783033) was registered on 16 March 2026 at Unit 7 Springfort Retail Park, Nenagh, Tipperary — the latest in a series of Irish business name registrations by the Australian pharmacy giant. Chemist Warehouse has been expanding aggressively in Ireland since its 2023 entry, targeting retail parks and high-footfall locations. The Nenagh registration suggests the rollout is now reaching secondary towns beyond the major cities. Watch for: further registrations in Midlands and regional towns as the company builds national coverage.
This week's filing queue contains two companies that reward deeper investigation: one a quietly profitable Sandyford healthcare group with a sprawling related-party network, the other a Dundrum-based healthcare billing platform that has quietly become one of Ireland's most internationally ambitious services businesses. Both filed consolidated accounts in the same week — and together they tell the story of Irish healthcare services in 2025.
Beacon Medical Group Limited — Debt-Free, Profitable, and Quietly Expanding
Beacon Medical Group Limited (CRO: 456723) is the holding company for a group of healthcare and related services businesses operating from Beacon Mall, Sandyford, Dublin 18. The group's principal activities include healthcare services, dialysis, car parking, property development, and management services. It is controlled by two directors: Mark Redmond (Director, 14,732 shares) and Michael Cullen (Director and Secretary, 25,313 shares). Neither director drew any remuneration during the year.
| Metric | FY2025 (Jun) | FY2024 (Jun) | Change |
|---|---|---|---|
| Revenue | €16.10M | €15.85M | +1.6% |
| Gross Profit Margin | 48% | 47% | +1pp |
| Operating Profit | €2.49M | €2.91M | −14.5% |
| Profit After Tax | €2.31M | €2.02M | +14.4% |
| Total Assets | €25.54M | €23.83M | +7.2% |
| Net Assets | €17.29M | €14.98M | +15.4% |
| Cash at Bank | €2.43M | €1.13M | +114.5% |
| Bank Debt | €0 | €0 | — |
| Employees | 97 | 95 | +2 |
The most revealing line in Beacon Medical Group's accounts is not the revenue figure — it's the investment property revaluation. The group's investment property rose from €4.7 million to €4.955 million during the year, a €255,000 gain recognised in the P&L. This is property pledged as security for a loan from RELM — a lender that specialises in commercial real estate. The group also advanced €1.845 million to Beacon Medical Holdings (a related party) during the year, bringing the total outstanding to €171,426 after repayments. The so what: Beacon Medical Group is not just a healthcare operator — it is a property-backed, cash-generative business with a complex web of related-party relationships that extends to Beacon Nursing Homes, Beacon Hospital Sandyford, and Beacon Care Fertility. The filing of this set of accounts is a window into the entire Beacon ecosystem.
The question for 2026 accounts: will the group's operating profit recover from its 14.5% decline, and will the investment property continue to appreciate as Sandyford commercial values stabilise?
Medical Account Services Limited — The Healthcare SaaS Company Nobody Talks About
Medical Account Services Limited (CRO: 396597) was incorporated in January 2005 and operates from the 6th Floor, Rockfield Central, Dundrum, Dublin 16. Its principal activity is providing billing and accounts receivable management services for healthcare professionals — in plain English, it handles the administrative and financial back-office for doctors, consultants, and clinics. The company is controlled by John Loughrey (Director) and Cormac Loughrey (Secretary), who together hold 575 of the 580 issued shares.
| Metric | FY2025 (Apr) | FY2024 (Apr) | Change |
|---|---|---|---|
| Revenue | €21.41M | €18.13M | +18.1% |
| Operating Profit | €118K | €254K | −53.5% |
| Profit After Tax (group) | €52K | €168K | −69.0% |
| Profit Attributable to Parent | €115K | €176K | −34.7% |
| Cash at Bank | €4.88M | €5.71M | −14.5% |
| Bank Debt | €67K | €107K | −37.4% |
| Net Assets | €3.20M | €3.18M | +0.8% |
| Pension Contributions | €238K | €307K | −22.5% |
The apparent paradox in Medical Account Services' accounts — revenue growing at 18% while profit attributable to the parent fell 35% — is explained by the company's investment in international expansion. Administrative expenses grew from €17.9 million to €21.3 million, absorbing almost all of the revenue gain. The UK subsidiary (Medserv Limited) owed the parent €336,930 at year-end, suggesting it is still in a net investment phase. The Polish subsidiary (MAS Polska Sp. z.o.o.) owed the parent €333,232. The so what: this is a company deliberately sacrificing short-term profit for long-term market position. The director loan of €181,797 advanced during the year — accruing interest and repayable within one year — is a minor concern but worth watching. The 2026 accounts will reveal whether the international subsidiaries have moved to profitability.
The question for 2026 accounts: have the UK and Polish subsidiaries reached breakeven, and has the 18% revenue growth rate been sustained as the company scales its international operations?
Key People This Period
| Name | Role | Notable Activity | Connections |
|---|---|---|---|
| Mark Redmond | Director | Beacon Medical Group FY2025 filed; profit €2.31M, zero bank debt | Beacon Medical Group, Beacon Dialysis, Beacon Medical Holdings, Cerdera (property) |
| Michael Cullen | Director & Secretary | Holds 63% of Beacon Medical Group shares; no remuneration drawn | Beacon Medical Group |
| John Loughrey | Director | Medical Account Services revenue +18% to €21.4M; international expansion | Medical Account Services, Medserv Ltd (UK), MAS Polska (Poland) |
| Cormac Loughrey | Secretary & Director | Increased shareholding from 475 to 525 shares; director loan €181,797 | Medical Account Services |
| Dan McCarthy | Director & Secretary | Classes Lake Pharmacy group: pharmacy, vet, pub, dairy farm; €12.9M revenue | Classes Lake Pharmacy, DMC Pharmacy, Dan McCarthy Veterinary |
| Timothy McCutcheon | CEO & Chairman | Ovoca Bio pivoting from pharma to Morocco mining; going concern flag | Ovoca Bio PLC (AIM/Euronext Growth) |
One to Watch: Classes Lake Pharmacy Ltd
Classes Lake Pharmacy Ltd
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | €12.92M | €12.32M |
| Profit Before Tax | €151K | €228K |
| Interest Costs | €336K | €298K |
| Long-Term Debt | €1.99M | €1.56M |
| Deferred PAYE/PRSI | €681K | €0 |
| Employees | 100 | 105 |
What they do: Classes Lake Pharmacy Ltd is the holding company for a Cork-based group that operates four pharmacy shops (under the DMC Pharmacy and related brands), a veterinary practice (Dan McCarthy Veterinary Ltd), a public house, and a dairy farm. The group is controlled through a "golden share" structure — a legal mechanism that gives the holder of a single A ordinary share the right to control the board, regardless of overall shareholding. This allows Dan McCarthy to consolidate the group's accounts while maintaining flexible ownership structures across each subsidiary.
Why it matters: This is one of the most unusual diversified groups in the CRO's weekly filing queue. The combination of pharmacy, veterinary, hospitality, and agriculture under a single consolidated balance sheet is rare — and the golden share structure is rarer still. The group's €681K in deferred PAYE/PRSI (warehoused under the pandemic scheme and now appearing as a long-term liability) is a structural overhang that will require careful management as it falls due. The group's interest costs rose 13% to €336K, squeezing a profit margin that was already thin. The so what: this is a family business with genuine diversification, but the debt structure needs attention.
The number that matters: €681,802 — the deferred PAYE/PRSI liability that appeared for the first time in the FY2025 balance sheet. This is pandemic-era tax debt that was warehoused by Revenue and is now being recognised as a long-term liability. It represents 49% of the group's total long-term debt and will need to be repaid over the coming years. Watch for: how the group manages this liability in the FY2026 accounts, and whether the pharmacy margin holds as Chemist Warehouse expands into Cork's hinterland.
The Irish Courts
The Irish courts delivered one significant business-relevant judgment in the week of 12–16 March 2026: a High Court ruling on data centre planning permission in County Clare. The case is directly relevant to the corporate activity visible in this week's CRO filings — the Wtech Fire story and the broader infrastructure buildout that is driving demand for fire protection, energy management, and data services in Ireland.
| Citation | Parties | Subject | Why It Matters |
|---|---|---|---|
| [2026] IEHC 156 | Doyle & Ors v An Coimisiún Pleanála & Ors [No. 3] | Data centre planning permission, Clare; climate change, bat EIA, CPPAs | High Court upholds data centre permission; confirms climate legislation does not require refusal of data centre applications where CPPA conditions are included |
Mr Justice Humphreys dismissed a challenge to a data centre planning permission in County Clare, finding that An Coimisiún Pleanála's decision fell within the lawful spectrum of options under climate legislation. The applicants — environmental groups and local residents — argued that the commission's decision was inconsistent with Ireland's Climate Action Plan 2023 and failed to adequately assess bat fauna impacts. The court rejected both grounds. The so what for business readers: this judgment provides significant legal certainty for data centre developers in Ireland. The requirement for corporate power purchase agreements (CPPAs) for renewable energy — included as a planning condition — is now confirmed as a lawful and sufficient climate mitigation measure. Watch for: further data centre planning applications in regional locations, particularly in areas with available grid capacity.
Property Markets & Plans
The Irish property market recorded 425 transactions in the week of 12–16 March 2026, with an average price of €468,601 and a median of €352,423. The gap between average and median — €116,000 — reflects the continued influence of high-value transactions on the overall average. The week's largest transaction reached €29.1 million, consistent with a commercial or multi-unit residential deal. No direct property transactions were identified for the companies featured in this week's CRO filings, though Beacon Medical Group's investment property in Sandyford — valued at €4.955 million — is pledged as security for a RELM commercial loan.
| Metric | Value | Signal |
|---|---|---|
| Total transactions (week) | 425 | Active market |
| Average price | €468,601 | Above median |
| Median price | €352,423 | Market level |
| Largest transaction | €29.1M | Top deal |
| Lowest transaction | €10 | Non-market |
The Week Ahead
The dominant theme of the week of 12–16 March 2026 is the quiet strength of Irish healthcare services — a sector that is generating real revenue, real profit, and real employment, largely outside the public eye. The three healthcare groups that filed consolidated accounts this week — Beacon Medical Group, Medical Account Services, and Classes Lake Pharmacy — collectively employ nearly 300 people and generate over €50 million in revenue. None of them are household names. All of them are growing. The single most important takeaway from this period: the CRO's financial filing queue is a better indicator of the health of the Irish economy than any single macro statistic. This week's queue says: healthcare is strong, micro-enterprise is active, and the international expansion of Irish services businesses is accelerating.
Ireland's private healthcare sector is quietly consolidating, its billing infrastructure is going international, and its most unusual family businesses are navigating pandemic-era debt overhangs with characteristic resilience. The CRO data this week tells a story of an economy that is growing in the sectors that matter — and contracting in the sectors that don't.
What to Watch:
- Beacon Medical Holdings Limited accounts — expected at the CRO in the coming months. The €1.845 million advance from Beacon Dialysis Services during FY2025 will need to be explained.
- Medical Account Services FY2026 accounts — will the UK and Polish subsidiaries have reached breakeven? The 18% revenue growth rate is the key metric to watch.
- Ovoca Bio PLC — the conditional acquisition of Moroccan copper and silver exploration licences is the company's last viable pivot. Watch for a definitive announcement on the Tadeen International deal.